Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,087 Dermatology
clinical trials

Atopic Dermatitis Clinical Trial
Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.
Status: Enrolling, Phase II
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Sebacia Postmarket Study of Real-World Use
Status: Enrolling
Updated: 12/31/1969
Austin Institute for Clinical Research, Inc. - Central
mi
from
Austin, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Academic Centers Research and Education
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Olympian Clinical Research
mi
from
Largo, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Suncoast Research Associates
mi
from
Miami, FL
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 12/31/1969
Avant Research Associates LLC
mi
from
Austin, TX
Click here to add this to my saved trials
Alopecia Areata Clinical Trial
Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults Patients With Alopecia Areata
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Common Wart Clinical Trial
Safety Study of A-101 Topical Solution for the Treatment of Common Warts
Status: Enrolling, Phase III
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Aventura, FL
Click here to add this to my saved trials
Common Wart Clinical Trial
Safety Study of A-101 Topical Solution for the Treatment of Common Warts
Status: Enrolling, Phase III
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
Common Wart Clinical Trial
Safety Study of A-101 Topical Solution for the Treatment of Common Warts
Status: Enrolling, Phase III
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
Common Wart Clinical Trial
Safety Study of A-101 Topical Solution for the Treatment of Common Warts
Status: Enrolling, Phase III
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Fridley, MN
Click here to add this to my saved trials
Common Wart Clinical Trial
Safety Study of A-101 Topical Solution for the Treatment of Common Warts
Status: Enrolling, Phase III
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Common Wart Clinical Trial
Safety Study of A-101 Topical Solution for the Treatment of Common Warts
Status: Enrolling, Phase III
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Newnan, GA
Click here to add this to my saved trials
Common Wart Clinical Trial
Safety Study of A-101 Topical Solution for the Treatment of Common Warts
Status: Enrolling, Phase III
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Hidradenitis Suppurativa Clinical Trial
This is a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS).
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
East Melbourne,
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Hematology, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Status: Enrolling, Phase
Updated: 12/31/1969
Central Ohio Breast and Endocrine Surgery
mi
from
Gahanna, OH
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Hematology, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Status: Enrolling, Phase
Updated: 12/31/1969
Saint Alphonsus Medical Center-Ontario
mi
from
Ontario, OR
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Hematology, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Status: Enrolling, Phase
Updated: 12/31/1969
Genesis Healthcare System Cancer Care Center
mi
from
Zanesville, OH
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Pulmonary / Respiratory Diseases Clinical Trial
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling, Phase
Updated: 3/27/2018
Landspitali University Hospital
mi
from
Reykjavik,
Click here to add this to my saved trials
Human Papillomavirus Infection Clinical Trial
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
Status: Enrolling, Phase III
Updated: 4/18/2014
Clinical Research Facility
mi
from
Augusta, GA
Click here to add this to my saved trials
Human Papillomavirus Infection Clinical Trial
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
Status: Enrolling, Phase III
Updated: 4/18/2014
Clinical Research Facility
mi
from
Newport News, VA
Click here to add this to my saved trials
Human Papillomavirus Infection Clinical Trial
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
Status: Enrolling, Phase III
Updated: 4/18/2014
Clinical Research Facility
mi
from
Redlands, CA
Click here to add this to my saved trials
Human Papillomavirus Infection Clinical Trial
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
Status: Enrolling, Phase III
Updated: 4/18/2014
Clinical Research Facility
mi
from
Valley Village, CA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
Status: Enrolling, Phase III
Updated: 12/31/1969
Univ of Puerto Rico
mi
from
San Juan,
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling, Phase II
Updated: 1/21/2016
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling, Phase II
Updated: 1/21/2016
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Beverly, MA
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Fort Gratiot, MI
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)
Status: Enrolling, Phase III
Updated: 7/6/2016
Glenmark Investigational Site 49
mi
from
Tempe, AZ
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)
Status: Enrolling, Phase III
Updated: 7/6/2016
Glenmark Investigational Site 57
mi
from
West Columbia, SC
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 2/28/2017
Clinical Research Facility
mi
from
Pflugerville, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Arlington, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Bay City, MI
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Forest Hills, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Lake Worth, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Medford, OR
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Rockville, MD
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
South Burlington, VT
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Washington DC,
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
West Dundee, IL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Wilmington, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Orthopedics / Podiatry Clinical Trial
Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
Status: Enrolling, Phase II
Updated: 12/31/1969
New Life Medical Research Center
mi
from
Hialeah, FL
Click here to add this to my saved trials
Post-inflammatory Hyperpigmentation Clinical Trial
An In Vivo Model for Postinflammatory Hyperpigmentation
Status: Enrolling
Updated: 2/22/2017
Department of Dermatology, Henry Ford Medical Center, 3031 West Grand Boulevard
mi
from
Detroit, MI
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Phase 2 Safety and Efficacy Study of UHE-101 Cream in Subjects With Acne Vulgaris
Status: Enrolling, Phase II
Updated: 10/10/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Actinic Keratoses Clinical Trial
Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents
Status: Enrolling, Phase IV
Updated: 10/30/2017
University of Arizona, Banner-University Medical Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Neurology Clinical Trial
Brentuximab Vedotin for Systemic Sclerosis
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Medical University of South Carolina: Division of Rheumatology & Immunology
mi
from
Charleston, SC
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Study Site
mi
from
Columbus, GA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Orange, CA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
Scleroderma Clinical Trial
The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)
Status: Enrolling, Phase
Updated: 12/31/1969
Victoria K Shanmugam
mi
from
Washington DC,
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
MUSC SCTR Research Nexus Clinic and Laboratory
mi
from
Charleston, SC
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
NorthShore University HealthSystem Dermatology Clinical Trials Unit
mi
from
Skokie, IL
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis
Status: Enrolling, Phase II
Updated: 12/31/1969
Colorado Skin Care
mi
from
Englewood, CO
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis
Status: Enrolling, Phase II
Updated: 12/31/1969
Ciocca Dermatology
mi
from
Miami, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Australian Clinical Research Network Pty Ltd
mi
from
Maroubra,
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis
Status: Enrolling, Phase IV
Updated: 12/31/1969
IMMUNOe RESEARCH CENTERS
mi
from
Thornton, CO
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study of Baricitinib (LY3009104) in Adults With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/2/2018
mi
from
Buenos Aires,
Click here to add this to my saved trials
Urticaria Clinical Trial
Efficacy and Safety of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of British Columbia
mi
from
Vancouver,
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Tien Q. Nguyen, MD inc. DBA First OC Dermatology
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Olympian Clinical Research
mi
from
Largo, FL
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Research Center, Inc. - Los Alamitos Site
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Suncoast Research Associates
mi
from
Miami, FL
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
DS Research
mi
from
New Albany, IN
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Wilmington Health Family Medicine (X-Ray only)
mi
from
Wilmington, NC
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Treasure Valley Dermatology
mi
from
Boise, ID
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Dermatologists of Southwest Ohio, Inc.
mi
from
Mason, OH
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Arlington Dermatology
mi
from
Rolling Meadows, IL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Medical Research
mi
from
Sandy Springs, GA
Click here to add this to my saved trials
Diffuse Cutaneous Systemic Sclerosis Clinical Trial
Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Status: Enrolling, Phase III
Updated: 12/31/1969
Rutgers Clinical Research Center, Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
Ketoconazole in Treating Participants With Ongoing EGFR Inhibitor-Induced Rash
Status: Enrolling, Phase
Updated: 12/31/1969
Regions Cancer Care Center
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Ichthyosis Vulgaris Clinical Trial
A Six Week Topical Cream Study for Subjects With Ichthyosis Vulgaris
Status: Enrolling, Phase II
Updated: 12/31/1969
Crown Investigative Site 05
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 516
mi
from
Bexley, OH
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 18
mi
from
Cleveland, OH
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 210
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 519
mi
from
Orange Park, FL
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 361
mi
from
San Antonio, TX
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 226
mi
from
Webster, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
Status: Enrolling, Phase II
Updated: 12/31/1969
Synexus
mi
from
Greer, SC
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
Status: Enrolling, Phase II
Updated: 12/31/1969
Unity Clinical Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
Status: Enrolling, Phase II
Updated: 12/31/1969
Dermatology Consulting Services
mi
from
Tampa, FL
Click here to add this to my saved trials
1 … 10 11 12 13 14 15 16 17 18 19 20 21